EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection

Hsin-Ju Tsai, Ming-Ju Wu, Cheng-Hsu Chen, Sheng-Shun Yang, Yi-Hsiang Huang, Yan-Zin Chang, Horng-Rong Chang, Teng-Yu Lee

Transplant International · 2023

DOI: 10.3389/ti.2023.11122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, 2023. Verfasst von Hsin-Ju Tsai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Kidney Transplantation, Hepatitis B. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taichung Veterans General Hospital, Chung Shan Medical University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prophylaxis strategy for hepatitis B virus (HBV) reactivation in kidney transplant recipients (KTRs) with resolved HBV infection remains unclear. In this hospital-based retrospective cohort study, consecutive KTRs with resolved HBV infection were screened from the years 2000 through 2020. After excluding confounding conditions, 212 and 45 patients were respectively recruited into Anti-HBs positive and Anti-HBs negative groups. Cumulative incidences of, and subdistribution hazard ratios (SHRs) for HBV reactivation were analyzed after adjusting the competing risk. During a median 8.3 (mean 8.4 ± 4.9) years of follow-up, the 10-year cumulative incidence of HBV reactivation was significantly higher in Anti-HBs negative group when compared to that in Anti-HBs positive group (15.2%, 95% CI: 3.6–26.7 vs. 1.3%, 95% CI: 0.0–3.0; p < 0.001). In multivariable regression analysis, absence of anti-HBs (SHR 14.2, 95% CI: 3.09–65.2; p < 0.001) and use of high-dose steroids, i.e., steroid dose ≥20 mg/day of prednisolone equivalent over 4 weeks (SHR 8.96, 95% CI: 1.05–76.2; p = 0.045) were independent risk factors related to HBV reactivation. Accordingly, the 10-year cumulative incidence of HBV reactivation occurring in patients with two, one and zero risk factors was 42.7% (95% CI: 0.0–87.1), 7.9% (95% CI: 1.2–14.7) and 0%, respectively ( p < 0.001). In conclusion, the strategy of HBV antiviral prophylaxis may be defined according to the risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHepatitis BHumansHepatitis B virusRetrospective StudiesHepatitis B Surface AntigensAntiviral AgentsHepatitis B AntibodiesTransplant RecipientsVirus ActivationRisk Assessment

Stichwörter der Autor:innen

antiviral therapyhepatitis Bimmunosuppressionrenal transplantationreversion

Substanzen

Hepatitis B Surface AntigensAntiviral AgentsHepatitis B Antibodies

Autor:innen und Institutionen

  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.

Förderung

  • Taichung Veterans General Hospital
  • Chung Shan Medical University Hospital

Zitieren

APA

Tsai, H. J., Wu, M. J., Chen, C. H., Yang, S. S., Huang, Y. H., Chang, Y. Z., Chang, H. R., & Lee, T. Y. (2023). Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection. Transplant International. https://doi.org/10.3389/ti.2023.11122

Vancouver

Tsai HJ, Wu MJ, Chen CH, Yang SS, Huang YH, Chang YZ, et al. Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection. Transplant International. 2023. doi:10.3389/ti.2023.11122

BibTeX
@article{Tsai2023,
  author = {Tsai, Hsin-Ju and Wu, Ming-Ju and Chen, Cheng-Hsu and Yang, Sheng-Shun and Huang, Yi-Hsiang and Chang, Yan-Zin and Chang, Horng-Rong and Lee, Teng-Yu},
  title = {Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection},
  journal = {Transplant International},
  year = {2023},
  doi = {10.3389/ti.2023.11122}
}
Kostenlos starten →